148 related articles for article (PubMed ID: 20677260)
1. Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium.
Karam AR; Shankar S; Surapaneni P; Kim YH; Hussain S
J Magn Reson Imaging; 2010 Aug; 32(2):341-4. PubMed ID: 20677260
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and distinguishing features of hepatocellular adenoma and focal nodular hyperplasia on gadoxetate disodium-enhanced MRI.
Purysko AS; Remer EM; Coppa CP; Obuchowski NA; Schneider E; Veniero JC
AJR Am J Roentgenol; 2012 Jan; 198(1):115-23. PubMed ID: 22194486
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of MRI in differentiating hepatocellular adenoma from focal nodular hyperplasia: prospective study of the additional value of gadoxetate disodium.
Bieze M; van den Esschert JW; Nio CY; Verheij J; Reitsma JB; Terpstra V; van Gulik TM; Phoa SS
AJR Am J Roentgenol; 2012 Jul; 199(1):26-34. PubMed ID: 22733890
[TBL] [Abstract][Full Text] [Related]
5. Focal nodular hyperplasia: a weight-based, intraindividual comparison of gadobenate dimeglumine and gadoxetate disodium-enhanced MRI.
Taibbi A; Brancatelli G; Matranga D; Midiri M; Lagalla R; Bartolotta TV
Diagn Interv Radiol; 2019 Mar; 25(2):95-101. PubMed ID: 30860073
[TBL] [Abstract][Full Text] [Related]
6. Hepatic enhancement during the hepatobiliary phase after gadoxetate disodium administration in patients with chronic liver disease: the role of laboratory factors.
Chernyak V; Kim J; Rozenblit AM; Mazzoriol F; Ricci Z
J Magn Reson Imaging; 2011 Aug; 34(2):301-9. PubMed ID: 21608069
[TBL] [Abstract][Full Text] [Related]
7. MR findings of focal eosinophilic liver disease using gadoxetic acid.
Lee J; Park CM; Kim KA; Lee CH; Choi JW
Magn Reson Imaging; 2010 Nov; 28(9):1327-34. PubMed ID: 20800984
[TBL] [Abstract][Full Text] [Related]
8. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.
Marin D; Brancatelli G; Federle MP; Lagalla R; Catalano C; Passariello R; Midiri M; Vilgrain V
Clin Radiol; 2008 May; 63(5):577-85. PubMed ID: 18374723
[TBL] [Abstract][Full Text] [Related]
9. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
10. Magnetic resonance imaging findings of atypical focal nodular hyperplasia of the liver.
Asbach P; Klessen C; Koch M; Hamm B; Taupitz M
Clin Imaging; 2007; 31(4):244-52. PubMed ID: 17599618
[TBL] [Abstract][Full Text] [Related]
11. Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver.
Ringe KI; Husarik DB; Sirlin CB; Merkle EM
AJR Am J Roentgenol; 2010 Jul; 195(1):13-28. PubMed ID: 20566794
[TBL] [Abstract][Full Text] [Related]
12. Hyperintense lesions on gadoxetate disodium-enhanced hepatobiliary phase imaging.
Kim MJ; Rhee HJ; Jeong HT
AJR Am J Roentgenol; 2012 Nov; 199(5):W575-86. PubMed ID: 23096201
[TBL] [Abstract][Full Text] [Related]
13. Hepatic focal nodular hyperplasia: diagnosis by ultrafast Gd-DTPA enhanced FLASH MR.
Urhahn R; Klose KC; Drobnitzky M
J Comput Assist Tomogr; 1991; 15(5):848-51. PubMed ID: 1885810
[TBL] [Abstract][Full Text] [Related]
14. Focal nodular hyperplasia of the liver: detection and characterization with plain and dynamic-enhanced MRI.
Mortelé KJ; Praet M; Van Vlierberghe H; de Hemptinne B; Zou K; Ros PR
Abdom Imaging; 2002; 27(6):700-7. PubMed ID: 12395259
[TBL] [Abstract][Full Text] [Related]
15. Multiple focal nodular hyperplasia syndrome: diagnosis with dynamic, gadolinium-enhanced MRI.
Finley AC; Hosey JR; Noone TC; Shackelford DM; Varadarajulu S
Magn Reson Imaging; 2005 Apr; 23(3):511-3. PubMed ID: 15862653
[TBL] [Abstract][Full Text] [Related]
16. Gadoxetate Disodium versus Gadoterate Meglumine: Quantitative Respiratory and Hemodynamic Metrics by Using Compressed-Sensing MRI.
Glessgen CG; Moor M; Stieltjes B; Winkel DJ; Block TK; Merkle EM; Heye TJ; Boll DT
Radiology; 2019 Nov; 293(2):317-326. PubMed ID: 31549944
[TBL] [Abstract][Full Text] [Related]
17. Gadoxetate disodium-enhanced MRI of the liver: part 2, protocol optimization and lesion appearance in the cirrhotic liver.
Cruite I; Schroeder M; Merkle EM; Sirlin CB
AJR Am J Roentgenol; 2010 Jul; 195(1):29-41. PubMed ID: 20566795
[TBL] [Abstract][Full Text] [Related]
18. [The dynamic magnetic resonance study of focal liver lesions by FLASH sequences with bolus intravenous gadolinium-DTPA].
Olivetti L; Grazioli L; Maroldi R; Matricardi L; Milanesio L
Radiol Med; 1992 Apr; 83(4):353-60. PubMed ID: 1318558
[TBL] [Abstract][Full Text] [Related]
19. Imaging of focal liver lesions: the 90 %-rule.
Mostbeck G
Ultraschall Med; 2010 Dec; 31(6):545-7. PubMed ID: 21117006
[No Abstract] [Full Text] [Related]
20. [Differentiation of focal liver lesions using contrast-enhanced MRT].
Heintz P; Ehrenheim C
Rofo; 1989 Mar; 150(3):297-306. PubMed ID: 2538880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
